Nesfatin-1 Level in Patients With Type 2 Diabetes, Insulin Resistance and Obesity
NCT ID: NCT04298515
Last Updated: 2020-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
180 participants
INTERVENTIONAL
2020-03-02
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sestrin-2 Levels and Insulin Resistance
NCT06779721
The Effect of Fasting on Serum Osmolarity in Diabetic Patients
NCT04392570
Diurnal Variability in the Regulation of Beta-cell Function and Insulin Sensitivity in Overweight People
NCT02011581
Does the Energy Restriction Intermittent Fasting Diet Alleviate Metabolic Syndrome Biomarkers?
NCT04502329
Clinical Feasibility and Efficacy of Intermittent Use of a Fasting Mimicking Diet in the Treatment of Type 2 Diabetes
NCT03811587
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Type 2 Diabetes group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
Nesfatin-1
Blood will be taken from the patients on an empty stomach for measuring nesfatin-1 level
Insulin resistance group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
Nesfatin-1
Blood will be taken from the patients on an empty stomach for measuring nesfatin-1 level
Obesity group
In case of fasting, blood will be taken from patients for the measurement of nesfatin-1.
Nesfatin-1
Blood will be taken from the patients on an empty stomach for measuring nesfatin-1 level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nesfatin-1
Blood will be taken from the patients on an empty stomach for measuring nesfatin-1 level
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Insulin resistance
* Obesity disease
Exclusion Criteria
* All patients who are hospitalized,
* Liver disease
* Cancer patients
* Disease related to the gastrointestinal tract
* Nephrological disease such as chronic kidney failure, acute kidney failure, nephrotic syndrome
* Neurological disease
19 Years
79 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gülin Öztürk Özkan
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülin Öztürk Özkan, Assis Prof
Role: STUDY_CHAIR
İstanbul Medeniyet University
Kadir Kayataş, associate professor
Role: STUDY_DIRECTOR
Haydarpaşa Numune Education and Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haydarpaşa Numune Education and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Dore R, Levata L, Lehnert H, Schulz C. Nesfatin-1: functions and physiology of a novel regulatory peptide. J Endocrinol. 2017 Jan;232(1):R45-R65. doi: 10.1530/JOE-16-0361. Epub 2016 Oct 17.
Mirzaei K, Hossein-nezhad A, Keshavarz SA, Koohdani F, Eshraghian MR, Saboor-Yaraghi AA, Hosseini S, Chamari M, Zareei M, Djalali M. Association of nesfatin-1 level with body composition, dietary intake and resting metabolic rate in obese and morbid obese subjects. Diabetes Metab Syndr. 2015 Oct-Dec;9(4):292-8. doi: 10.1016/j.dsx.2014.04.010. Epub 2014 May 25.
Li QC, Wang HY, Chen X, Guan HZ, Jiang ZY. Fasting plasma levels of nesfatin-1 in patients with type 1 and type 2 diabetes mellitus and the nutrient-related fluctuation of nesfatin-1 level in normal humans. Regul Pept. 2010 Jan 8;159(1-3):72-7. doi: 10.1016/j.regpep.2009.11.003.
Related Links
Access external resources that provide additional context or updates about the study.
Original research
Original research
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HNEAH-KAEK 2019/100
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.